Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Queener

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Journal of Clinical Microbiology|December 1, 1992
An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivoM M Durkin, M S Bartlett, S F Queener, et al.
The Journal of Protozoology|November 1, 1991
An ELISA method for quantitation of Pneumocystis carinii in culture and lungM M Durkin, M S Bartlett, S F Queener, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 10, 2004
Comparison of ternary complexes of Pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolateV Cody, N Galitsky, J R Luft, et al.
Journal of Medicinal Chemistry|September 25, 1997
Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agentsC Robson, M A Meek, J D Grunwaldt, et al.
Journal of Medicinal Chemistry|October 15, 1993
2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductaseA Rosowsky, C E Mota, J E Wright, et al.
Clinical and Diagnostic Laboratory Immunology|September 1, 1994
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytesM S Bartlett, W L Current, A Orazi, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed miceM S Bartlett, T D Edlind, C H Lee, et al.
Journal of Clinical Microbiology|June 1, 1993
Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasksC H Lee, N L Bauer, M M Shaw, et al.
Journal of Medicinal Chemistry|June 6, 1997
Structural studies on bioactive compounds. 28. Selective activity of triazenyl-substituted pyrimethamine derivatives against Pneumocystis carinii dihydrofolate reductaseM F Stevens, K S Phillip, D L Rathbone, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Lipophilic antifolates as candidates against opportunistic infectionsJ R Piper, C A Johnson, C A Hosmer, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Journal of Clinical Microbiology|December 1, 1992
An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivoM M Durkin, M S Bartlett, S F Queener, et al.
The Journal of Protozoology|November 1, 1991
An ELISA method for quantitation of Pneumocystis carinii in culture and lungM M Durkin, M S Bartlett, S F Queener, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 10, 2004
Comparison of ternary complexes of Pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolateV Cody, N Galitsky, J R Luft, et al.
Journal of Medicinal Chemistry|September 25, 1997
Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agentsC Robson, M A Meek, J D Grunwaldt, et al.
Journal of Medicinal Chemistry|October 15, 1993
2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductaseA Rosowsky, C E Mota, J E Wright, et al.
Clinical and Diagnostic Laboratory Immunology|September 1, 1994
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytesM S Bartlett, W L Current, A Orazi, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed miceM S Bartlett, T D Edlind, C H Lee, et al.
Journal of Clinical Microbiology|June 1, 1993
Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasksC H Lee, N L Bauer, M M Shaw, et al.
Journal of Medicinal Chemistry|June 6, 1997
Structural studies on bioactive compounds. 28. Selective activity of triazenyl-substituted pyrimethamine derivatives against Pneumocystis carinii dihydrofolate reductaseM F Stevens, K S Phillip, D L Rathbone, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Lipophilic antifolates as candidates against opportunistic infectionsJ R Piper, C A Johnson, C A Hosmer, et al.
Pageof 13